BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11234881)

  • 21. [Serum levels of several chemokines in patients with rheumatoid arthritis].
    Wu HX; Zhang Y; Zhu YL
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):534-7. PubMed ID: 15949333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
    Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum chemokine profiles in patients with alopecia areata.
    Kuwano Y; Fujimoto M; Watanabe R; Ishiura N; Nakashima H; Ohno Y; Yano S; Yazawa N; Okochi H; Tamaki K
    Br J Dermatol; 2007 Sep; 157(3):466-73. PubMed ID: 17489976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation.
    Nomura S; Ishii K; Kanazawa S; Inami N; Kamitsuji Y; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2006 Apr; 15(4):247-53. PubMed ID: 16635746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage.
    Günel N; Coskun U; Sancak B; Hasdemir O; Sare M; Bayram O; Celenkoglu G; Ozkan S
    Am J Clin Oncol; 2003 Aug; 26(4):416-21. PubMed ID: 12902898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.
    Winter PM; Dung NM; Loan HT; Kneen R; Wills B; Thu le T; House D; White NJ; Farrar JJ; Hart CA; Solomon T
    J Infect Dis; 2004 Nov; 190(9):1618-26. PubMed ID: 15478067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
    Soria G; Yaal-Hahoshen N; Azenshtein E; Shina S; Leider-Trejo L; Ryvo L; Cohen-Hillel E; Shtabsky A; Ehrlich M; Meshel T; Keydar I; Ben-Baruch A
    Cytokine; 2008 Oct; 44(1):191-200. PubMed ID: 18790652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating interleukin-15 and RANTES chemokine in Parkinson's disease.
    Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
    Acta Neurol Scand; 2007 Dec; 116(6):374-9. PubMed ID: 17986095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of interleukin-10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma.
    Majima T; Ichikura T; Seki S; Takayama E; Matsumoto A; Kawabata T; Chochi K; Hiraide H; Mochizuki H
    Anticancer Res; 2002; 22(2B):1193-9. PubMed ID: 12168924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum big endothelin-1 levels in female patients with breast cancer.
    Yildirim Y; Gunel N; Coskun U; Sancak B; Bukan N; Aslan S; Cetin A
    Int Immunopharmacol; 2008 Aug; 8(8):1119-23. PubMed ID: 18550016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
    Dehqanzada ZA; Storrer CE; Hueman MT; Foley RJ; Harris KA; Jama YH; Shriver CD; Ponniah S; Peoples GE
    Oncol Rep; 2007 Mar; 17(3):687-94. PubMed ID: 17273752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
    Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
    Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
    Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
    Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
    Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.